Clinical Trials Directory

Trials / Completed

CompletedNCT02725359

Tizanidine and Superficial Cervical Block on Pain After Thyroidectomy

Preemptive Single Dose Tizanidine and Ultrasound Guided Superficial Cervical Block on Pain After Thyroidectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ataturk University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Thyroid surgery is a quite painful procedure performed in a sensitive skin area of the human body. Unless pain is treated adequately thyroid surgery may cause severe postoperative pain and discomfort for the patients. a2-Agonists are sympatholytic and centrally acting antihypertensive agents. In addition to their hypotensive effect, a2-agonists are also used in anesthetic practice for their sedative and analgesic effects. Tizanidine is a centrally acting a2-agonist with muscle relaxant, sedative and anxiolytic properties. This drug is widely used for the treatment of spasticity and has recently been used to treat musculoskeletal pain conditions. Ultrasound (US) guidance during regional anesthesia practices has been a revolutionary advancement to improve success and safety of regional anesthesia. Analgesic effect of US guidance superficial cervical plexus block (SCPB) in patients undergoing thyroid surgery has not been reported yet. The aim of this study was to evaluate the analgesic effect of preemptive oral single dose tizanidine and US guidance SCPB in patients undergoing elective thyroid surgery. The investigators hypothesis that: Tizanidine and US guided SCPB can reduce the pain scores, analgesic consumption, analgesic related side effects.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboGroup Placebo: will receive a placebo pill 1 hour before surgery
DRUGTizanidineGroup T: 6 mg tizanidine1 hour before surgery
DRUGBupivacaineGroup Bupivacaine will receive USG guided SCPB with %0,25 bupivacaine bilaterally 10 ml each side
DRUGSalineUSG guided SCPB with saline bilaterally 10 ml each side

Timeline

Start date
2016-04-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-04-01
Last updated
2016-12-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02725359. Inclusion in this directory is not an endorsement.